HCG & Enclomiphene: Testosterone Restoration That Preserves Fertility

Hormone Optimization — Testosterone

HCG & Enclomiphene: Testosterone Restoration That Preserves Fertility

Traditional testosterone replacement therapy shuts down the body’s own hormone production and suppresses sperm counts. HCG and enclomiphene take a different approach — restoring testosterone from within the axis rather than replacing it from outside.

The Problem With Standard TRT for Younger Men

Exogenous testosterone — injected, applied, or implanted from outside the body — works well for symptom relief but comes with a significant trade-off. When the brain detects elevated testosterone in the bloodstream, it suppresses LH (luteinizing hormone) and FSH (follicle-stimulating hormone) output from the pituitary. LH normally signals the testes to produce testosterone; FSH signals them to produce sperm. Suppress both, and testicular function winds down: testicular atrophy is common, and sperm counts often drop to zero.

For men who have completed their families or are not concerned about fertility, this trade-off may be acceptable. For men who want to have children, or who value maintaining testicular function and their body’s own hormonal axis, it’s a significant problem. HCG and enclomiphene address this by working with the axis rather than bypassing it.

What Is HCG?

Human chorionic gonadotropin (HCG) is a hormone that mimics LH at the LH receptor on Leydig cells in the testes. By directly stimulating the testes to produce testosterone — the same signal LH normally delivers — HCG raises testosterone levels while keeping the testes active. Because the signal to produce sperm (FSH) is not suppressed, sperm production continues alongside testosterone production.

HCG is used in several contexts in men’s hormonal health: as a standalone therapy to raise testosterone while preserving fertility, as an adjunct to TRT to maintain testicular size and sperm production, and as a fertility treatment in men with hypogonadotropic hypogonadism. It is administered by subcutaneous injection, typically 2–3 times per week.

What Is Enclomiphene?

Enclomiphene is the active isomer of clomiphene, a selective estrogen receptor modulator (SERM). It works at the level of the hypothalamus and pituitary — the control centers upstream of the testes — rather than acting on the testes directly. By blocking estrogen receptors in the brain, enclomiphene reduces the estrogen-mediated negative feedback that suppresses LH and FSH release. The result is increased LH and FSH output, which in turn stimulates the testes to produce more testosterone and maintain sperm production.

Enclomiphene offers a compelling profile for certain men: it is taken orally (once daily), it raises both testosterone and FSH simultaneously, and clinical trials have shown it can normalize testosterone while maintaining or even improving sperm parameters. It is not yet FDA-approved for male hypogonadism as of this writing, but it is widely used off-label by men’s health specialists.

What the Evidence Shows

HCG has decades of clinical use in male reproductive medicine. Its effectiveness for raising testosterone and preserving testicular function is well established. For men on TRT who add HCG, studies consistently show maintenance of testicular volume and improved sperm parameters compared to TRT alone.

Enclomiphene has a smaller but growing evidence base. Phase II and III trials conducted by its developer (Repros Therapeutics) demonstrated statistically significant improvements in testosterone levels and sperm counts compared to placebo, with a favorable side-effect profile. A key advantage over clomiphene (the racemic mixture) is the absence of zuclomiphene, the other isomer, which has a long half-life and can produce estrogenic effects that blunt the desired response.

Honest bottom line: Both HCG and enclomiphene are well-regarded tools in the men’s health specialist’s toolkit for men who want testosterone optimization without shutting down fertility. Neither is a perfect substitute for exogenous testosterone in all cases — some men’s testes will not respond adequately — but for many, they represent a meaningful alternative that respects the body’s own hormonal infrastructure.

Who Is a Candidate?

  • Men with hypogonadism who want to preserve or restore fertility
  • Men on TRT who want to maintain testicular function alongside their current therapy
  • Younger men with secondary hypogonadism (the problem is pituitary or hypothalamic, not testicular) where stimulation of the axis makes physiological sense
  • Men who have been on TRT and want to come off while recovering natural production
  • Men who want testosterone optimization but prefer to avoid exogenous hormones

These therapies are less likely to work in men with primary testicular failure (where the testes themselves cannot respond to LH signals), or in men with very severe hypogonadism where the testicular reserve is exhausted. A thorough hormonal evaluation including LH, FSH, and testosterone levels is essential before prescribing either.

What to Expect

With HCG, testosterone levels typically rise within the first few weeks of treatment. Optimal dosing requires individual titration; most men are managed on 500–1500 IU administered 2–3 times per week, though protocols vary. Some men notice a significant improvement in energy, libido, and mood that parallels the testosterone rise.

With enclomiphene, testosterone typically begins to rise within 2–4 weeks of daily oral dosing. Many men achieve mid-normal or upper-normal testosterone ranges. Response varies, and some men reach a ceiling below their target; in those cases, combination strategies or transition to exogenous therapy may be appropriate.

Risks and Considerations

HCG’s most common side effects are related to its LH-mimicking action: increased estrogen production (which the testes also produce) can lead to gynecomastia in susceptible men, managed with an aromatase inhibitor when necessary. Some men experience injection site reactions or mood sensitivity with high-dose HCG.

Enclomiphene’s side effect profile is generally mild. Visual disturbances, a known concern with clomiphene, appear to be less common with enclomiphene due to the absence of zuclomiphene. Estrogen levels should be monitored — the testosterone rise brings a corresponding rise in estradiol, and some men may require management of elevated estrogen symptoms.

Both therapies require ongoing monitoring of hormone levels. Regular bloodwork (testosterone, estradiol, LH, FSH, hematocrit) is part of responsible management. Neither therapy should be started, adjusted, or discontinued without physician involvement.

Explore Testosterone Options With a Specialist

A men’s health provider can evaluate your hormone levels and help determine whether HCG, enclomiphene, or another approach is right for your goals.

Find a Provider
Patient Reviews

Share Your Experience

Your review helps other patients make informed decisions about their care.

What Patients Are Saying

There are no reviews yet. Be the first one to write one.